Evidence map›Paper›PMID 39839473›Full record

ArticleFrontiers in endocrinology2024

Case report: Prolonged and severe hungry bone syndrome after parathyroidectomy in X-linked hypophosphatemia.

Giulia Puliani, Valeria Hasenmajer, Matteo Spaziani, Federico Frusone, Chiara Tarantino, Francesco Angelini, Ludovica Vincenzi, Riccardo Lubrano, Alessia Marcellino, Marco Biffoni and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giulia PulianiOncological Endocrinology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy.
Valeria HasenmajerDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Matteo SpazianiDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Federico FrusoneDepartment of Surgical Sciences, Sapienza University of Rome, Rome, Italy.
Chiara TarantinoDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Francesco AngeliniDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Ludovica VincenziDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Riccardo LubranoPediatrics and Neonatology Unit, Maternal-Child Department, Santa Maria Goretti Hospital, Sapienza University of Rome, Rome, Italy.
Alessia MarcellinoPediatrics and Neonatology Unit, Maternal-Child Department, Santa Maria Goretti Hospital, Sapienza University of Rome, Rome, Italy.
Marco BiffoniDepartment of Surgical Sciences, Sapienza University of Rome, Rome, Italy.
Andrea M IsidoriDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tertiary hyperparathyroidism is characterized by hypercalcemia resulting from autonomous parathyroid hormone production and usually occurs after a prolonged period of secondary hyperparathyroidism. This condition can be a complication of X-linked hypophosphatemia (XLH), a rare genetic disease characterized by renal phosphate loss and consequent hypophosphatemia. Parathyroidectomy is considered the first-line therapy but surgical intervention can be complicated by hungry bone syndrome. A male Caucasian patient presented with XLH, diagnosed at the age of 3 years. At the age of 21, tertiary hyperparathyroidism occurred. Neck ultrasonography, neck magnetic resonance imaging, and

Indexed as

Familial Hypophosphatemic RicketsHyperparathyroidism, SecondaryHypocalcemiaParathyroidectomyPostoperative ComplicationsHumansMaleSyndromeYoung AdultburosumabFGF23hungry bone syndromeparathyroidectomytertiary hyperparathyroidismX-linked hypophosphatemia

Identifiers

PMID39839473
PMCPMC11746029

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.